Curanex Pharmaceuticals (CURX) Current Leases (2025)

Curanex Pharmaceuticals' (CURX) quarterly Current Leases came in at $122689.0 in Q4 2025, up 100.64% on a QoQ basis from $61150.0 in Q3 2025.

Curanex Pharmaceuticals (CURX) Current Leases (2025) Analysis & Trends

Curanex Pharmaceuticals (CURX) has 1 years of Current Leases data on file, last reported at $122689.0 in Q4 2025.

Quarterly Current Leases changed N/A year-over-year to $122689.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $122689.0 (changed N/A YoY) and the FY2025 annual result came in at $122689.0, changed N/A from the prior year.
Current Leases advanced to $122689.0 in Q4 2025, from $61150.0 in the prior quarter.
In the past five years, Current Leases ranged from a high of $122689.0 in Q4 2025 to a low of $61150.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	720.00 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	21.95 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	45.93 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	6.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-
10	Curanex Pharmaceuticals	6.11 Mn	1.11 Mn	-	122,689.00

Download Data